Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation

Respiratory Medicine

Volumn 105, Issue SUPPL. 1, 2011, Pages

  Stanojkovic, Ivana ^a   Kotur Stevuljevic, Jelena ^a   Milenkovic, Branislava ^b,c   Spasic, Slavica ^a   Vujic, Tatjana ^c   Stefanovic, Aleksandra ^a   Llic, Aleksandra ^b,c   Ivanisevic, Jasmina ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

COPD; Inflammation; Oxidative stress; Paraoxonase 1; Prooxidant antioxidant balance

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROL GROUP; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME ACTIVITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SUPEROXIDE DISMUTASE;

EID: 80054997454     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/S0954-6111(11)70008-7     Document Type: Article

References (28)

1. AW Boots, GRAAM Haenen, A Bast Oxidant metabolism in chronic obstructive pulmonary disease Eur Respir J 22 2003 14 27
2. W MacNee Oxidative stress and Chronic Obstructive Pulmonary Disease.fur Respir monograph 11 2006 100 129
3. S von Haehling, SD Anker Cachexia as a major underestimated and unmet medical need: facts and numbers J Cachexia Sarcopenia Muscle 1 2010 1 5
4. AG Agusti, A Noguera, J Sauleda, E Sala, J Pons, X Busqets Systemic effects of chronic obstructive pulmonary disease Eur Respir J 21 2003 347 360 (Pubitemid 36204553)
5. AE Camilli, DR Robbins, MD Lebowitz Death certificate reporting of confirmed airways obstructive disease Am J Epidemiol 133 1991 795 800
6. SM Curkendall, C DeLuise Jones JK, Lanes S, Stang MR, Goehring E Jr, She D. Cardiovascular disease patients with chronic obstructive pulmonary disease, Saskatchewan, Canada Cardiovascular Disease in COPD patients Ann Epidemiol 16 2006 63 70 (Pubitemid 41783891)
7. W MacNee, J Maclay, D McAllister Cardiovascular Injury and Repair in chronic obstructive pulmonary disease Proc Am Thorac Soc 5 2008 824 833
8. KF Rabe, S Hurd, A Anzueto et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary Am J Respir Crit Care Med 176 2007 532 555 (Pubitemid 47403272)
9. BR Celli, W MacNee Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur Respir J 23 2004 932 946 (Pubitemid 38807371)
10. R Rodriguez Roisin Toward a consensus definition for COPD exacerbation Chest 117 Suppl 2 2000 398S 401S
11. MG Felkor, LK Shaw, CM O'Connor A standardized definition of ischemic cardiomyopathy for use in clinical research J Am Coll Card/of 39 2002 210 218 (Pubitemid 34084623)
12. MR Miller, R Crapo, J Hankinson, V Brusasco et al. Standardisation of spirometry ATS/ERS task force: standardization of lung function testing Eur Respir J 26 2005 319 338
13. J Kotur-Stevuljevic, L Memon, A Stefanovic et al. Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients Clin Biochem 40 2007 181 187 (Pubitemid 46111070)
14. V Witko-Sarsat, M Friedlander, C Capeillere-Blandin et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia Kidney Int 49 1996 1304 1313 (Pubitemid 26166404)
15. O Erel A new automated method for measuring total oxidant status Clin Biochem 38 2005 1103 1111
16. J Kotur-Stevuljevic, S Spasic, A Stefanovic, A Zeljkovic et al. Paraoxonase-1 (P0N1) activity, but PON1(0-192R) phenotype, is a predictor of coronary artery disease in a middle-aged Serbian population Clin Chem Lab Med 44 2006 1206 1213
17. DH Alamdari, MG Mobarhan, s Tavallaie, MR Parizadeh, M Moohebati, F Ghafoori, SMRK Bajestani, K Paletas, T Pegiou, G Koliakos Pro-oxidant- antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease Clin Biochem 41 2008 375 380
18. W MacNee Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease Proc Am Thorac Soc 2 2005 50 60 (Pubitemid 40562963)
19. I Rahman, D Morrison, K Donaldson, W MacNee Systemic oxidative stress in asthma, COPD and smokers Am J Respir Crit Care Med 154 1996 1055 1060
20. I Rahman, E Skwarska, W MacNee Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease Thorax 52 1997 565 568 (Pubitemid 27298512)
21. DD Sin, SFP Man Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular disease? The potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 107 2003 1514 1519 (Pubitemid 36378490)
22. RJ Tkacova, D Petrasova, Z Kluchova, P Joppa, R Klimcik, Z Dorkova Lipid peroxidation and glutathion peroxidase activity in patients with COPD: relationship to disease severity Chest 128 2005 131S
23. E Alfuntas, T Tukgut, N llhan, F Deveci, HM Muz, J Celik The levels of oxidant and antioxidant in patients with chronic obstructive pulmonary disease Tuberk Torax 51 2003 373 379
24. JJ Cataluna, MA Garcia Cardiovascular comorbidity in chronic obstructive pulmonary disease Arch Broncopneumol 45 2009 18 23
25. W Doehner, S von Haehling, SD Anker, M Lainscak Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review Wien Klin Wochenschr 121 2009 293 296
26. S von Haehling, M Lainscak, J Springer, S Anker Cardiac cachexia: A systematic overview Pharmacol Ther 121 2009 227 252
27. G Gornicka, J Beltowski, G Wojcicka, A Jomroz Serum paraoxonase activity, total antioxidant potential and lipid peroxidation products in children with bronchial asthma exacerbation Wiad Lek 55 2002 257 263
28. G Tolgyesi, V Molnar, AF Semsei, P Kiszel, I Ungvari, P Pocza et al. Gene expression profiling of experimental asthma reveals a posible role of paraoxonase-1 in the disease Int Immunol 21 2009 967 975